Abrostep DM Tablet: Triple Therapy for Allergic and Obstructive Airway Disease
Cafoli Lifecare is committed to delivering superior therapeutic solutions, and Abrostep DM Tablet is a prime example of our dedication to respiratory excellence. This precise formulation of Acebrophylline 200mg + Desloratadine 5mg + Montelukast 10mg is engineered to provide comprehensive, synergistic relief for patients managing Allergic Asthma, Allergic Rhinitis, and COPD with a strong allergic component.
Scientific Profile & Mechanism of Action
This powerful combination features Acebrophylline (bronchodilator/mucolytic), Desloratadine (a non-sedating, long-acting antihistamine), and Montelukast (a potent leukotriene receptor antagonist). This triple-action approach simultaneously addresses bronchospasm, histamine release, and inflammatory cascade, providing superior control over chronic respiratory symptoms.
Manufactured in our WHO-GMP certified facilities, Abrostep DM Tablet guarantees the highest standards of safety and efficacy, building trust with physicians across India.
Strategic Partnership & Supply Advantages
We invite ethical drug distribution partners and high-volume wholesalers to collaborate on this high-demand product. Secure exclusive territory rights and benefit from our competitive pricing structure. We guarantee reliable bulk supply for hospitals and institutions, offering excellent resale profit margins and dedicated marketing support for your pharmaceutical distribution business.
Contact Cafoli Lifecare today for wholesale pricing and distribution rights.